San Francisco, CA, United States of America

Clement S Chu

This inventor holds 24 USPTO granted patents and 22 published patent applications and 5 EPO patents, primarily in DNA Detection Methods. Top assignees: Myriad Women's Health, Inc., Counsyl, Inc.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clement S Chu. Retrieved from https://idiyas.com/inventor/clement-s-chu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 104(Granted Patents)


Location History:

  • San Francisco, CA (US) (2015 - 2024)
  • South San Francisco, CA (US) (2019 - 2024)

Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Circulating Tumor DNA
Nucleic Acid Sequencing
Prenatal Diagnostics
Cell-Free DNA
DNA Enrichment
Genetic Variation
Automated Detection
Combinatorial Screening
DNA Fraction Preparation
Target Polynucleotides
Sequencing Adapters
DNA Sample Analysis
24 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Clement S. Chu

Introduction

Clement S. Chu is a distinguished inventor based in San Francisco, CA, with a remarkable portfolio of 16 patents. His innovative work primarily revolves around the field of genetics and molecular biology, focusing on methods for detecting DNA and analyzing biological samples. Through his contributions, he has significantly advanced the understanding of genetic markers associated with diseases.

Latest Patents

Among his latest patents are two groundbreaking innovations. The first patent, titled "Methods of Detecting DNA in a Sample," outlines advanced techniques for identifying unique genetic signatures derived from various mutations in nucleic acids. This method demonstrates high sensitivity, allowing for non-invasive detection of mutations linked to diseases such as cancer and inherited conditions. The second patent, "Methods of Preparing a DNA Fraction Enriched with Circulating Tumor DNA," provides a comprehensive laboratory execution system. This system emphasizes automation and central data management, streamlining complex analytical processes to enhance the detection of specific molecules of interest in the lab.

Career Highlights

Clement has made substantial contributions to notable companies in the health and genetics sector, including Myriad Women's Health, Inc. and Counsyl, Inc. His innovative approach and dedication to research have been instrumental in developing technologies that aid in disease diagnosis and treatment.

Collaborations

Throughout his career, Clement has had the opportunity to work alongside talented professionals such as Eric Andrew Evans and Noah C. Welker. These collaborations have fostered a rich exchange of ideas and have been critical in the advancement of their collective research efforts.

Conclusion

Clement S. Chu stands out as an influential inventor whose work is paving the way for new approaches to genetic diagnostics. His innovative patents and collaborative spirit continue to drive advancements in the field, contributing to the understanding and treatment of genetic diseases. As he progresses in his career, the impact of his inventions is likely to resonate in the medical and scientific communities for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…